Sharda Cropchem

Sharda Cropchem delivered a stellar Q4 FY26, with revenue growing 13% YoYCurrent reported value: 13% YoY. No comparable prior figure is available in the source record. to ₹2,065Current reported value: 2,065. No comparable prior figure is available in the source record. crore, EBITDA surging 75%Current reported value: 75%. No comparable prior figure is available in the source record. to ₹513Current reported value: 513. No comparable prior figure is available in the source record. crore (margin 24.8%Current reported value: 24.8%. No comparable prior figure is available in the source record., up 750bps), and PAT rising 57%Current reported value: 57%. No comparable prior figure is available in the source record. to ₹319Current reported value: 319. No comparable prior figure is available in the source record. crore. The full year saw revenue of ₹5,268 crore (+22% YoY) and PAT of ₹681 crore (+124% YoY). Growth was driven by volume expansion (+4.3%Current 4.3%. Reported change: +4.3pp YoY. in Q4, +13.4% full year) and favorable forex (+11.7% in Q4), partially offset by negative price/mix (-3.0%). Gross margins expanded 750bps to 37.3% due to better product mix and pricing discipline. Management guided FY27 revenue growth of 10-15%Current reported value: 10-15%. No comparable prior figure is available in the source record., gross margins around 35%, and EBITDA margins of 18-20%. Key risks include geopolitical uncertainty from the Middle East war and potential raw material price increases, though management believes 80-90% of cost increases can be passed on due to limited competition from registration barriers.